TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/22/23 16:47 | 3/20/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -34 | 7.76 | 0 | -4 | -4 | 102 | D | ||||||||||||||
2/22/23 20:58 | 2/17/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -25 | 7.45 | 0 | -3 | -3 | 107 | D | ||||||||||||||
2/15/23 16:52 | 2/13/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -22 | 7.67 | 0 | -3 | -3 | 110 | D | ||||||||||||||
1/19/23 16:57 | 1/17/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -22 | 9.85 | 0 | -2 | -2 | 113 | D | ||||||||||||||
4/6/22 16:34 | 4/4/22 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -23 | 8.25 | 0 | -3 | -2 | 115 | D | ||||||||||||||
3/23/22 18:39 | 3/21/22 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hesslein Robert W. | MA | O | SVP,GC | S | -41 | 8.29 | 0 | -5 | -4 | 118 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |